Alternatives to Organovo

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

AI-driven digital twin of embryo development for cell-based therapies.

Develops autologous engineered tissue from omentum biopsies for medical conditions.

North American subsidiary of CTIBIOTECH, a leader in 3D bioprinting of human tissue.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Mapping cell-cell communication at scale in human tissue.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

BICO Group is a global leader in life science solutions, enabling the bioprinting and analysis of cells, tissues, and organs.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

AI platform for embryonic phenotyping that accelerates drug discovery and toxicology testing by automating analysis of embryos and organoids.

AI-powered platform accelerating biological research and drug discovery.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-powered platform for real-time organ physiology to accelerate human-relevant drug discovery.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

AI-driven drug discovery platform for rapid development of novel therapeutics.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Biotech company developing novel therapeutics for regenerative medicine and oncology.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

AI-powered drug discovery and development platform for biologics.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotech company developing next-generation gene writing tools for advanced therapies.

Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Biotechnology company developing novel immunotherapies for cancer.

Advance every cancer decision.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Plant-based bio-compounds for food and life sciences.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Seevix Material Sciences develops and produces SVX, a proprietary spider silk protein, for various industrial and medical applications.